ATyr Pharma Inc. said its chief business officer, Sanuj Ravindran, will leave the company.
Ravindran will be employed until Dec. 31. He will transition from being the chief business officer of the company to an advisory role.
Meanwhile, Mark Goldberg resigned from the board due to other commitments. Goldberg had served as a director since 2015.
